AVDL AVADEL PHARMACEUTICALS PLC Management Changes 8-K Filing 2023 - Amendment Approval at Annual Meeting Avadel Pharmaceuticals plc held its 2023 Annual Meeting of Shareholders and shareholders approved an amendment to the Company's 2020 Omnibus Incentive Compensation Plan, increasing the number of shares authorized for issuance by 6,500,000 shares.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC